Robert D. Thompson,Anthony Beauglehole,Guoquan Wang
申请号:
US15094903
公开号:
US09593118B2
申请日:
2016.04.08
申请国别(地区):
US
年份:
2017
代理人:
摘要:
The present invention provides xanthine-substituted alkynyl carbamates/reverse carbamates and derivatives thereof and pharmaceutical compositions containing the same that are selective antagonists of A2B adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.